YD Bio YDESW
NASDAQ YDESW
$0.41 -0.06 (-12.77%)
At close: Sep 8, 2026 · 4:00 PM EDT

YD Bio (YDESW) Other Non-Current Assets (2024 - 2026)

YD Bio's (YDESW) quarterly Other Non-Current Assets came in at $1.9 million in Q2 2026, up 32.83% year-over-year from $1.5 million in Q2 2025, and up 35.36% quarter-over-quarter from $1.4 million in Q4 2025.

Analysis

YD Bio (YDESW) Other Non-Current Assets (2024 - 2026) Analysis & Trends

YD Bio (YDESW) has reported Other Non-Current Assets for 3 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets rose 32.83% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $1.9 million, a 32.83% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 127.89% from the prior year.
  • Other Non-Current Assets was $1.9 million for Q2 2026 at YD Bio, up from $1.4 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $1.9 million in Q2 2026 and troughed at $628232.0 in Q4 2024.
  • A 3-year average of $1.4 million and a median of $1.4 million in 2025 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets jumped 127.89% in 2025 and soared 32.83% in 2026, its largest moves.
  • Over 3 years, Other Non-Current Assets stood at $628232.0 in 2024, then jumped by 127.89% to $1.4 million in 2025, then soared by 35.36% to $1.9 million in 2026.
  • The last three Other Non-Current Assets figures came in at $1.9 million (Q2 2026), $1.4 million (Q4 2025), and $1.5 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 211.55 Bn 197.56 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 181.17 Bn 177.99 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 132.18 Bn 124.33 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 82.50 Bn 74.50 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 61.66 Bn 56.48 Bn 1.37 Bn 124.00 Mn
6 Moderna 54.61 Bn 49.47 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 34.17 Bn 30.86 Bn 992.69 Mn 65.13 Mn
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 30.04 Bn 30.04 Bn 1.16 Mn 29.59 Mn
10 YD Bio 29.02 Mn 26.36 Mn - 1.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.94 Mn
Dec 31, 2025 1.43 Mn
Jun 30, 2025 1.46 Mn
Dec 31, 2024 628,232.00